Eplerenone Tablet, Film Coated
Product Images NDC 51991-877

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eplerenone (NDC 51991-877). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Eplerenone 01)

FDA Label Image

Figure 3 (Eplerenone 02)

FDA Label Image

Figure 4 (Eplerenone 03)

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Principal Display Panel (25 mg Tablet Bottle Label)
This appears to be a medication information label for Eplerenone Tablets, with a dosage and usage instruction, child-resistant container warning, lot number, and distribution information. The medication contains 25g of Eplerenone and is distributed by Brioiee Parmuceuic. The manufacturer is MSN Laboratoris Private Limited in Telangana, India. The rest of the text seems to be unclear or unrelated.*
FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Principal Display Panel (50 mg Tablet Bottle Label)
Each tablet of Eplerenone contains 0mg. It has an NDC number of 51991-878-90 and the expiry date of 1ss 04/2020. The DOSAGE AND USE is not available as the text is incomplete and has errors.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.